Quillivant XR 25 MG/5 ML susp 120ML
Ended Awarded
- Contract number
- SPE2DR26FG1DU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,607
Award facts
- Contract value 100% obligated
- $1,606.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,606.79 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), a medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company holds extensive contract authority to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. No set-aside provision was used for this award, indicating it was awarded through open competition. The delivery order reflects the company's ongoing role as a primary pharmaceutical supplier within the DLA's global medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FG1DU?
SPE2DR26FG1DU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FG1DU worth?
The government has obligated $1,607 on SPE2DR26FG1DU.
Is contract SPE2DR26FG1DU an order under another contract?
Yes. SPE2DR26FG1DU is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1DU competed?
The extent of competition for SPE2DR26FG1DU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award